Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.38 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.38 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.33 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.32 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.31 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | NOS1 | P29475 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31751418 | 0.84 | KIF11 (0.41) | KIF11GABRA1GABRB3GABRG2GABRB2 | |
| SCHEMBL992639 | 0.82 | GABRA1 (0.47) | KIF11GABRA1GABRB3GABRG2TSHR | |
| SCHEMBL18969110 | 0.82 | KIF11 (0.41) | KIF11GABRA1GABRB3GABRG2ALDH1A1 | |
| SCHEMBL993831 | 0.82 | KIF11 (0.41) | KIF11GABRA1GABRB3GABRG2GABRB2 | |
| SCHEMBL993942 | 0.82 | KIF11 (0.45) | KIF11GABRA1GABRB3GABRG2GABRB2 | |
| Hydrochloric Acid SCHEMBL993872 | 0.80 | KIF11 (0.44) | KIF11GABRA1GABRB3GABRG2ADORA2A | |
| SCHEMBL17600537 | 0.80 | KIF11 (0.41) | KIF11GABRA1GABRB3GABRG2ALDH1A1 | |
| SCHEMBL15892710 | 0.79 | ESR1 (0.44) | KIF11GABRA1GABRB3GABRG2GABRB2 | |
| SCHEMBL18969775 | 0.79 | KIF11 (0.40) | KIF11GABRA1GABRB3GABRG2GABRB2 | |
| SCHEMBL23860299 | 0.78 | KIF11 (0.45) | KIF11GABRA1GABRB3GABRG2GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025262615-A1 | ANTIOXIDANTS CONTAINING DIAZIRINE FUNCTIONALITIES, COMPOSITIONS COMPRISING THEM AND USE THEREOF | BELLARE ANUJ (US) | 2025-12-26 | — | — | WO | claimed |
| US-12312741-B2 | Process for dyeing high-performance textiles | US GOVERNMENT AS REPRESENTED BY THE SECRETARY OF THE ARMY | 2025-05-27 | — | — | US | claimed |
| US-20250066997-A1 | PROCESS FOR DYEING HIGH-PERFORMANCE TEXTILES | GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 2025-02-27 | — | — | US | claimed |
| US-11322485-B2 | Mass transfer method for light-emitting unit, array substrate, and display device with electro-curable adhesive | BOE TECHNOLOGY GROUP CO., LTD. (CN) | 2022-05-03 | — | — | US | claimed |
| US-20210005582-A1 | MASS TRANSFER METHOD FOR LIGHT-EMITTING UNIT, ARRAY SUBSTRATE, AND DISPLAY DEVICE | BOE TECHNOLOGY GROUP CO., LTD. (CN) | 2021-01-07 | — | — | US | claimed |
| US-10005936-B2 | Photoactive bioadhesive compositions | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2018-06-26 | — | — | US | claimed |
| US-20170137693-A1 | ELECTRICALLY ACTIVATED ADHESIVE FOR STRENGTHENING OF A SUBTERRANEAN WELLBORE | SCHLUMBERGER NORGE, AS (NO) | 2017-05-18 | — | — | US | claimed |
| WO-2017081325-A1 | ELECTRICALLY ACTIVATED ADHESIVE FOR STRENGTHENING OF A SUBTERRANEAN WELLBORE | SCHLUMBERGER NORGE, AS (NO) | 2017-05-18 | — | — | WO | claimed |
| US-20150315434-A1 | New Photoactive Bioadhesive Compositions | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2015-11-05 | — | — | US | claimed |
| EP-4251216-B1 | SELF-REGULATING BIOADHESIVES FOR WET SUBSTRATES | UNIV NANYANG TECH (SG) | 2026-05-27 | — | — | EP | disclosed |
| EP-4003988-B1 | 3,6-DIAMINO-PYRIDAZIN-3-YL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS PRO-APOPTOTIC AGENTS | SERVIER LAB (FR) | 2026-05-20 | — | — | EP | disclosed |
| WO-2026099154-A1 | ADHESIVE DEVICE WITH HIGH BONDING STRENGTH | TESA SE (DE) | 2026-05-15 | — | — | WO | disclosed |
| WO-2026087555-A1 | METHOD FOR PRODUCING PLANAR, POROUS HYDROGELS BY MEANS OF FLOW LITHOGRAPHY | DWI - LEIBNIZ-INSTITUT FÜR INTERAKTIVE MATERIALIEN E.V. (DE) | 2026-04-30 | — | — | WO | disclosed |
| US-12527561-B2 | Electroceutical patch and catheter system and uses thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2026-01-20 | — | — | US | disclosed |
| US-20070098632-A1 | Analogs of terpene trilactones from ginkgo biloba and related compounds and uses thereof | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2007-05-03 | — | — | US | disclosed |
| US-7145021-B2 | Analogs of terpene trilactones from Ginkgo biloba and related compounds and uses thereof | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2006-12-05 | — | — | US | disclosed |
| US-6693091-B2 | CONTAINING PHOTOACTIVE, FLUORESCENT, OR RADIOACTIVE MOIETY | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2004-02-17 | — | — | US | disclosed |
| US-20030225052-A1 | Analogs of terpene trilactones from Ginkgo biloba and related compounds and uses thereof | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2003-12-04 | — | — | US | disclosed |
| US-20030194370-A1 | Analogs of terpene trilactones from ginkgo biloba for bioorganic and imaging studies | THE TRUSTEES OF COLUMBIA UNIVERSITY | 2003-10-16 | — | — | US | disclosed |
| WO-2003082185-A2 | ANALOGS OF TERPENE TRILACTONES FROM GINKGO BILOBA AND RELATED COMPOUNDS AND USES THEREOF | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2003-10-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10005936-B2 | Photoactive bioadhesive compositions | L1CAM, CDH1, PCNA | KIF11 2656/4885GABRA1 158/4885GABRB3 524/4885 |
| US-20070098632-A1 | Analogs of terpene trilactones from ginkgo biloba and related compounds and uses thereof | GRK5, GPR55, GPBAR1 | KIF11 3472/4885GABRA1 630/4885GABRB3 488/4885 |
| US-20030225052-A1 | Analogs of terpene trilactones from Ginkgo biloba and related compounds and uses thereof | GPBAR1, GRK5, CNR1 | KIF11 3870/4885GABRA1 601/4885GABRB3 445/4885 |
| US-12527561-B2 | Electroceutical patch and catheter system and uses thereof | TMED7, CALD1, ORAI1 | KIF11 753/4885GABRA1 1806/4885GABRB3 656/4885 |
| US-20030194370-A1 | Analogs of terpene trilactones from ginkgo biloba for bioorganic and imaging studies | GRK4, GRK1, GNB1 | KIF11 3989/4885GABRA1 1119/4885GABRB3 793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.